Discover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create life-changing medicines. Join our team and explore clinical trials.

Regeneron's medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurological diseases, hematologic conditions, infectious diseases and rare diseases.

Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. [2]

2024年10月31日 · Explore Regeneron’s pipeline of investigational medicines advancing through clinical trials for a range of serious diseases.

Location Amsterdam Armonk Austin Basel Basking Ridge Bengaluru Cambridge Cedar Rapids Co. Limerick Corpus Christi Des Moines Dublin East Greenbush Fort Wayne Hawthorne Houston Jackson Lexington-Fayette Los Angeles Louisville-Jefferson County5 Minato-Ku Mississauga Munich Nashville-Davidson6 New Orleans Paris Phoenix Remote - Arkansas Remote - …

2025年2月4日 · The Investor Relations website contains information about Regeneron Pharmaceuticals Inc.'s business for stockholders, potential investors, and financial analysts.

Search for a Regeneron clinical trial based on condition, keyword, and location. Explore comprehensive information on our highlighted trials to learn more.

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation.

Regeneron is a leading science and technology company dedicated to inventing, developing and commercializing life-transforming treatments for serious diseases. Our mission is to use the power of science to bring new medicines to patients… over and over again.

View Regeneron Pharmaceuticals, Inc. REGN stock quote prices, financial information, real-time forecasts, and company news from CNN.